Martha Chekenya
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.
Journal: NPJ precision oncology
Published: October 14, 2025
Reimagining Health-Care Ethics as an Ecosystem of Interdependent Climate-Conscious Roles and Responsibilities: Training New Generations of Health Researchers.
Journal: The American journal of bioethics : AJOB
Published: July 07, 2025
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 03, 2023
Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI.
Journal: Neuro-oncology advances
Published: May 08, 2023
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions.
Journal: PloS one
Published: August 26, 2022
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway.
Journal: Frontiers in cell and developmental biology
Published: August 18, 2022
Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy.
Journal: Cancers
Published: August 17, 2021
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.
Journal: Immunity, inflammation and disease
Published: March 21, 2020
Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival.
Journal: Cancers
Published: May 23, 2019
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival.
Journal: British journal of cancer
Published: April 26, 2019
Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors-Human Leukocyte Antigen Ligand Mismatch and Activation Receptor-Ligand Interactions.
Journal: Frontiers in immunology
Published: March 02, 2018
Last Updated: 09/26/2026